Keywords
Last Name

Benjamin Linas, MD

TitleAssociate Professor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionInfectious Diseases
Address771 Albany St
Boston MA 02118
Phone(617) 414-5238
ORCID ORCID Icon0000-0001-9574-7075
Other Positions
TitleAssociate Professor
InstitutionBoston University School of Public Health
DepartmentEpidemiology

 Research Expertise & Professional Interests
Viral Hepatitis
Hepatitis C Virus
HIV infection
Comparative effectiveness
Cost-Effectiveness
Simulation modeling
Data analytics
Transmission modeling
Health Economics
Health Policy

 Self-Described Keywords
  • Viral Hepatitis Hepatitis C Virus HIV infection Comparative effectiveness Cost-Effectiveness Simulation modeling Data analytics Transmission modeling Health Economics Health Policy
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Barocas JA, Beiser M, León C, Gaeta JM, O'Connell JJ, Linas BP. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017 Apr 10. PMID: 28395004.
    View in: PubMed
  2. Barocas JA, Linas BP. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis. Clin Infect Dis. 2017 Jan 01; 64(1):100-101. PMID: 27815292.
    View in: PubMed
  3. Linas BP. Understanding Cost and Value in Hepatitis C Therapy. Top Antivir Med. 2016 Jul/Aug; 24(2):93-97. PMID: 27841979.
    View in: PubMed
  4. Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Sep 06; 165(5):345-55. PMID: 27322622.
    View in: PubMed
  5. Barocas JA, Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Mar; 3(2):ofw075. PMID: 27191007.
    View in: PubMed
  6. Carey KJ, Huang W, Linas BP, Tsui JI. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. J Subst Abuse Treat. 2016 Jul; 66:54-9. PMID: 26988423.
    View in: PubMed
  7. Young KL, Huang W, Horsburgh CR, Linas BP, Assoumou SA. Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission. J Viral Hepat. 2016 Apr; 23(4):274-81. PMID: 26572798.
    View in: PubMed
  8. Pho MT, Jensen DM, Meltzer DO, Kim AY, Linas BP. Clinical impact of treatment timing for chronic hepatitis C infection: a decision model. J Viral Hepat. 2015 Aug; 22(8):630-8. PMID: 26135026.
    View in: PubMed
  9. Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 5; 162(9):619-29. PMID: 25820703.
    View in: PubMed
  10. Linas BP. Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries. J Infect Dis. 2015 Aug 15; 212(4):513-5. PMID: 25767215.
    View in: PubMed
  11. Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BP. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction. 2015 Jan; 110(1):129-43. PMID: 25291977.
    View in: PubMed
  12. Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP. Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care. Clin Infect Dis. 2014 Dec 15; 59(12):1686-93. PMID: 25186591.
    View in: PubMed
  13. Pho MT, Linas BP. Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy. Hepatology. 2014 Jul; 60(1):12-4. PMID: 24825115.
    View in: PubMed
  14. Linas BP, Barter DM, Leff JA, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Schackman BR. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One. 2014; 9(5):e97317. PMID: 24842841.
    View in: PubMed
  15. Assoumou SA, Huang W, Horsburgh CR, Drainoni ML, Linas BP. Relationship between hepatitis C clinical testing site and linkage to care. Open Forum Infect Dis. 2014 Mar; 1(1):ofu009. PMID: 25734083.
    View in: PubMed
  16. Assoumou SA, Huang W, Horsburgh CR, Mus, Linas BP. Quality of hepatitis C care at an urban tertiary care medical center. J Health Care Poor Underserved. 2014 May; 25(2):705-16. PMID: 24858880.
    View in: PubMed
  17. Linas BP, Hu H, Barter DM, Horberg M. Hepatitis C screening trends in a large integrated health system. Am J Med. 2014 May; 127(5):398-405. PMID: 24486288.
    View in: PubMed
  18. Linas BP, Barter DM, Leff JA, DiLorenzo M, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Freedberg KA. The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS. 2014 Jan 28; 28(3):365-76. PMID: 24670522.
    View in: PubMed
  19. Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH. The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic. AIDS Patient Care STDS. 2014 Jan; 28(1):4-9. PMID: 24428794.
    View in: PubMed
  20. Assoumou SA, Mayer KH, Panther L, Linas BP, Kim J. Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients. Sex Transm Dis. 2013 Apr; 40(4):298-303. PMID: 23486494.
    View in: PubMed
  21. Spaulding AS, Kim AY, Harzke AJ, Sullivan JC, Linas BP, Brewer A, Dickert J, McGovern BH, Strick LB, Trestman R, Ferguson WJ. Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. Top Antivir Med. 2013 Feb-Mar; 21(1):27-35. PMID: 23596276.
    View in: PubMed
  22. Linas BP, Wong AY, Schackman BR, Kim AY, Freedberg KA. Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. Clin Infect Dis. 2012 Jul; 55(2):279-90. PMID: 22491339.
    View in: PubMed
  23. Linas BP, Wong AY, Freedberg KA, Horsburgh CR. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011 Sep 1; 184(5):590-601. PMID: 21562129.
    View in: PubMed
  24. Linas BP, Wang B, Smurzynski M, Losina E, Bosch RJ, Schackman BR, Rong J, Sax PE, Walensky RP, Schouten J, Freedberg KA. The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat. 2011 Jul; 18(7):506-12. PMID: 20546501.
    View in: PubMed
  25. Linas BP, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA. Improving outcomes in state AIDS drug assistance programs. J Acquir Immune Defic Syndr. 2009 Aug 15; 51(5):513-21. PMID: 19561518.
    View in: PubMed
  26. Ehrenkranz PD, Pagán JA, Begier EM, Linas BP, Madison K, Armstrong K. Written informed-consent statutes and HIV testing. Am J Prev Med. 2009 Jul; 37(1):57-63. PMID: 19423271.
    View in: PubMed
  27. Linas BP, Zheng H, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA. Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis. 2006 Nov 15; 43(10):1357-64. PMID: 17051505.
    View in: PubMed
  28. Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KA. Assessing the impact of federal HIV prevention spending on HIV testing and awareness. Am J Public Health. 2006 Jun; 96(6):1038-43. PMID: 16670217.
    View in: PubMed
  29. Linas BP, Coffin PO, Backes G, Vlahov D. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000 Dec; 77(4):768-80. PMID: 11194316.
    View in: PubMed
  30. Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000 Dec; 77(4):781-93. PMID: 11194317.
    View in: PubMed
  31. Sulmasy DP, Linas BP, Gold KF, Schulman KA. Physician resource use and willingness to participate in assisted suicide. Arch Intern Med. 1998 May 11; 158(9):974-8. PMID: 9588430.
    View in: PubMed
  32. Schulman KA, Linas BP. Pharmacoeconomics: state of the art in 1997. Annu Rev Public Health. 1997; 18:529-48. PMID: 9143730.
    View in: PubMed
Benjamin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department